These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 14980676)

  • 1. DNA binding ligands targeting drug-resistant Gram-positive bacteria. Part 1: Internal benzimidazole derivatives.
    Bürli RW; McMinn D; Kaizerman JA; Hu W; Ge Y; Pack Q; Jiang V; Gross M; Garcia M; Tanaka R; Moser HE
    Bioorg Med Chem Lett; 2004 Mar; 14(5):1253-7. PubMed ID: 14980676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA binding ligands targeting drug-resistant Gram-positive bacteria. Part 2: C-terminal benzimidazoles and derivatives.
    Bürli RW; Jones P; McMinn D; Le Q; Duan JX; Kaizerman JA; Difuntorum S; Moser HE
    Bioorg Med Chem Lett; 2004 Mar; 14(5):1259-63. PubMed ID: 14980677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA binding ligands targeting drug-resistant bacteria: structure, activity, and pharmacology.
    Kaizerman JA; Gross MI; Ge Y; White S; Hu W; Duan JX; Baird EE; Johnson KW; Tanaka RD; Moser HE; Bürli RW
    J Med Chem; 2003 Aug; 46(18):3914-29. PubMed ID: 12930152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potent antibacterial activity of halogenated compounds against antibiotic-resistant bacteria.
    Vairappan CS; Kawamoto T; Miwa H; Suzuki M
    Planta Med; 2004 Nov; 70(11):1087-90. PubMed ID: 15549668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bottromycin derivatives: efficient chemical modifications of the ester moiety and evaluation of anti-MRSA and anti-VRE activities.
    Kobayashi Y; Ichioka M; Hirose T; Nagai K; Matsumoto A; Matsui H; Hanaki H; Masuma R; Takahashi Y; Omura S; Sunazuka T
    Bioorg Med Chem Lett; 2010 Oct; 20(20):6116-20. PubMed ID: 20833545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro effect of the presence of human albumin or human serum on the bactericidal activity of daptomycin against strains with the main resistance phenotypes in Gram-positives.
    Cafini F; Aguilar L; González N; Giménez MJ; Torrico M; Alou L; Sevillano D; Vallejo P; Prieto J
    J Antimicrob Chemother; 2007 Jun; 59(6):1185-9. PubMed ID: 17412725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pyrrolobenzodiazepine dimers: novel sequence-selective, DNA-interactive, cross-linking agents with activity against Gram-positive bacteria.
    Hadjivassileva T; Thurston DE; Taylor PW
    J Antimicrob Chemother; 2005 Sep; 56(3):513-8. PubMed ID: 16024592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis and structure-activity relationship studies of novel indazole analogues as DNA gyrase inhibitors with Gram-positive antibacterial activity.
    Tanitame A; Oyamada Y; Ofuji K; Kyoya Y; Suzuki K; Ito H; Kawasaki M; Nagai K; Wachi M; Yamagishi J
    Bioorg Med Chem Lett; 2004 Jun; 14(11):2857-62. PubMed ID: 15125947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and in vitro activity of dicationic bis-benzimidazoles as a new class of anti-MRSA and anti-VRE agents.
    Hu L; Kully ML; Boykin DW; Abood N
    Bioorg Med Chem Lett; 2009 Mar; 19(5):1292-5. PubMed ID: 19208475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pyrrolidine bis-cyclic guanidines with antimicrobial activity against drug-resistant Gram-positive pathogens identified from a mixture-based combinatorial library.
    Hensler ME; Bernstein G; Nizet V; Nefzi A
    Bioorg Med Chem Lett; 2006 Oct; 16(19):5073-9. PubMed ID: 16890437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative in vitro activity of tigecycline and other antimicrobials against Gram-negative and Gram-positive organisms collected from the Asia-Pacific Rim as part of the Tigecycline Evaluation and Surveillance Trial (TEST).
    Bouchillon SK; Iredell JR; Barkham T; Lee K; Dowzicky MJ
    Int J Antimicrob Agents; 2009 Feb; 33(2):130-6. PubMed ID: 18995992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro activity of tigecycline against quinolone-resistant Streptococcus pneumoniae, methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci.
    Garrison MW; Nuemiller JJ
    Int J Antimicrob Agents; 2007 Feb; 29(2):191-6. PubMed ID: 17174074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conformational constraint in oxazolidinone antibacterials. Synthesis and structure-activity studies of (azabicyclo[3.1.0]hexylphenyl)oxazolidinones.
    Renslo AR; Jaishankar P; Venkatachalam R; Hackbarth C; Lopez S; Patel DV; Gordeev MF
    J Med Chem; 2005 Jul; 48(15):5009-24. PubMed ID: 16033280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design and synthesis of benzenesulfonanilides active against methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus.
    Namba K; Zheng X; Motoshima K; Kobayashi H; Tai A; Takahashi E; Sasaki K; Okamoto K; Kakuta H
    Bioorg Med Chem; 2008 Jun; 16(11):6131-44. PubMed ID: 18468909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimization of the central linker of dicationic bis-benzimidazole anti-MRSA and anti-VRE agents.
    Hu L; Kully ML; Boykin DW; Abood N
    Bioorg Med Chem Lett; 2009 Jul; 19(13):3374-7. PubMed ID: 19481935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA binding ligands with in vivo efficacy in murine models of bacterial infection: optimization of internal aromatic amino acids.
    Bürli RW; Kaizerman JA; Duan JX; Jones P; Johnson KW; Iwamoto M; Truong K; Hu W; Stanton T; Chen A; Touami S; Gross M; Jiang V; Ge Y; Moser HE
    Bioorg Med Chem Lett; 2004 May; 14(9):2067-72. PubMed ID: 15080980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimicrobial resistance in gram-positive bacteria.
    Rice LB
    Am J Med; 2006 Jun; 119(6 Suppl 1):S11-9; discussion S62-70. PubMed ID: 16735146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Water-soluble pleuromutilin derivative with excellent in vitro and in vivo antibacterial activity against gram-positive pathogens.
    Hirokawa Y; Kinoshita H; Tanaka T; Nakata K; Kitadai N; Fujimoto K; Kashimoto S; Kojima T; Kato S
    J Med Chem; 2008 Apr; 51(7):1991-4. PubMed ID: 18330977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial susceptibility of tigecycline and comparators against bacterial isolates collected as part of the TEST study in Europe (2004-2007).
    Nørskov-Lauritsen N; Marchandin H; Dowzicky MJ
    Int J Antimicrob Agents; 2009 Aug; 34(2):121-30. PubMed ID: 19342205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro activity of ceftaroline (PPI-0903M, T-91825) against bacteria with defined resistance mechanisms and phenotypes.
    Mushtaq S; Warner M; Ge Y; Kaniga K; Livermore DM
    J Antimicrob Chemother; 2007 Aug; 60(2):300-11. PubMed ID: 17548456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.